ArticleDiabetology & metabolic syndrome2023

Clinical utility of a novel test for assessing cardiovascular disease risk in type 2 diabetes: a randomized controlled trial.

John W Peabody et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.